Jean‐Jacques Tuech

Integrative Analyses of Colorectal Cancer Show Immunoscore Is a Stronger Predictor of Patient Survival Than Microsatellite Instability

Bernhard Mlecnik, Gabriela Bindea, Helen K. Angell et al. · Immunity · 2016 · 1.1K citations · Full text

Medicine, Immunology, Oncology +14

Clinical relevance of KRAS mutation detection in metastatic colorectal cancer treated by Cetuximab plus chemotherapy

Frédéric FIORE, Frédéric Blanchard, F. Charbonnier et al. · British Journal of Cancer · 2007 · 734 citations · Full text

Medicine, Oncology, Pharmacology +17

Effect of Interval (7 or 11 weeks) Between Neoadjuvant Radiochemotherapy and Surgery on Complete Pathologic Response in Rectal Cancer: A Multicenter, Randomized, Controlled Trial (GRECCAR-6)

Jérémie H. Lefèvre, Laurent Mineur, Salma Kotti et al. · Journal of Clinical Oncology · 2016 · 472 citations

Medicine, Oncology, Surgery +17

Organ preservation for rectal cancer (GRECCAR 2): a prospective, randomised, open-label, multicentre, phase 3 trial

Éric Rullier, Philippe Rouanet, Jean‐Jacques Tuech et al. · The Lancet · 2017 · 378 citations

Medicine, Oncology, Surgery +17

Organ preservation with chemoradiotherapy plus local excision for rectal cancer: 5-year results of the GRECCAR 2 randomised trial

Éric Rullier, V. Vendrely, Julien Asselineau et al. · ˜The œLancet. Gastroenterology & hepatology · 2020 · 253 citations

Medicine, Oncology, Radiation Oncology +17